PEVAX
Price
$15.05
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
N/A
SSGSX
Price
$41.82
Change
-$0.10 (-0.24%)
Updated
May 22 closing price
Net Assets
5.67B
Interact to see
Advertisement

PEVAX vs SSGSX

Header iconPEVAX vs SSGSX Comparison
Open Charts PEVAX vs SSGSXBanner chart's image
PACE Small/Medium Co Value Equity A
Price$15.05
Change-$0.00 (-0.00%)
VolumeN/A
Net AssetsN/A
Victory Sycamore Small Company Opp A
Price$41.82
Change-$0.10 (-0.24%)
VolumeN/A
Net Assets5.67B
PEVAX vs SSGSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEVAX vs. SSGSX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEVAX is a Buy and SSGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEVAX pays higher dividends than SSGSX: PEVAX (0.77) vs SSGSX (0.54). PEVAX was incepted earlier than SSGSX: PEVAX (25 years) vs SSGSX (26 years). PEVAX (1.29) and SSGSX (1.26) have similar cost to investors . PEVAX is a more actively managed with annual turnover of: 119.00 vs. SSGSX (37.00). SSGSX (6%) and PEVAX (6%) have equivalent initial investment costs. PEVAX has a lower initial minimum investment than SSGSX: PEVAX (1000) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : -10.83 vs. PEVAX (-17.58). SSGSX return over 5 years is better than : 26.99 vs. PEVAX (5.39).
PEVAXSSGSXPEVAX / SSGSX
Total Expense Ratio1.291.26102%
Annual Report Gross Expense Ratio1.291.26102%
Fund Existence25 years26 years-
Gain YTD-4.908-7.21568%
Front Load6%6%96%
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A5.67B-
Annual Yield % from dividends0.770.54142%
Returns for 1 year-17.58-10.83162%
Returns for 3 years-21.79-5.32410%
Returns for 5 years5.3926.9920%
Returns for 10 years-23.039.83-234%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLCX72.77N/A
N/A
Rydex Leisure C
LEGCX48.91N/A
N/A
Columbia Large Cap Growth C
MNBAX19.75N/A
N/A
Manning & Napier Pro-Blend Extnd Term S
PMVFX24.75N/A
N/A
PGIM Quant Solutions Mid-Cap Val R4
MVISX41.00N/A
N/A
Patient Opportunity IS